CGTX - Cognition Therapeutics GAAP EPS of $0.17 beats by $0.46 May, 11 2022 07:23 AM Cognition Therapeutics Inc. Cognition Therapeutics press release (NASDAQ:CGTX): Q1 GAAP EPS of $0.17 beats by $0.46. Cash and cash equivalents of $51.51M For further details see: Cognition Therapeutics GAAP EPS of $0.17 beats by $0.46